It has shown benefit in chronic fatigue syndrome, fibromyalgia, and Parkinsons disease when administered intravenously
Get a one-time email the moment this lot is back
Cureus 16 , e52670 (2024)
The nausea and GI disruption that often follow injection can reduce probiotic absorption and increase the likelihood of vomiting the dose before it reaches the intestines
high blood pressure, PCOS) Patients with type 2 diabetes seeking better glucose control Individuals struggling with appetite control or metabolic resistance Those who havent succeeded with traditional diet and exercise alone Your eligibility will be determined after a full medical evaluation and lab testing
Ongoing trials aim to clarify: Cardiovascular safety Long-term weight durability Role in prediabetes and non-diabetic populations Comparison to semaglutide and tirzepatide Until then, we continue to emphasize current best practices: lifestyle support, personalized nutrition, advanced lipid testing, and thoughtful pharmacotherapy
